Life Sciences & Health Care
Quantum technologies help us truly understand, simulate and optimize the quantum properties of nature. This, in turn, unlocks enormous potential in the areas of biochemistry, pharmacogenomics, medical imaging, and others. We bring these possibilities to life.
Advancing Precision in Life Sciences with Quantum Intelligence
Unlock breakthrough possibilities in drug discovery, diagnostics, and biological simulation through high-fidelity quantum modeling and personalized healthcare pathways.
Molecular Dynamics Simulation
Predict and efficiently simulate the structure, properties, behavior and reactivity of small molecules (today) and large molecules in the near future, including exact methods for complete dynamic simulations – even atomic interactions.
Computer-Aided Drug Design
Accelerate the drug discovery process through achieving faster and higher-quality answers to challenges across Target Identification and Validation, Hit Generation and Lead Optimization. Large prospects for Anti-body and Peptide Therapeutics.
Personalization
Enable healthcare personalization with greater speed and efficacy than previously possible. Large prospects for Precision Medicine, Companion Diagnostics and Pharmacogenetics.
Operational Efficiencies
Enhance the delivery of healthcare services with the resources available, enabling better outcomes for patients within the existing budgetary and operational frameworks.
Metrology & Sensing
Provide ultra-high precision measuring that approaches the physical limits of measurement precision, known as the Heisenberg limits. This makes sub-cellular resolution and sensitivities possible, which enable mapping magnetic ions and nano structures in living cells as well as non-invasive detection of neuronal action.
"Big pharma could apply quantum computing to protein structure and interactions, an opportunity worth $200 billion. For GEM and advanced industries, the advent of quantum simulations of new materials and chemical compounds would make traditional chemical and clinical tests obsolete."
-McKinsey Digital
Use Case: Personalized Medicine Development
When simulating molecules, quantum computing can address this complex computing challenge in an unprecedented way, being a quantum system itself. In the process of drug discovery, the interaction between human proteins and the new medication is closely analysed.
With quantum computing, we can simulate these interactions more accurately and faster than any classical computer could do. Utilizing the unique capabilities, we can break it down to an individual level: Adjusting the treatment to the individual’s needs.
This way, we can speed up the overall drug discovery process, providing timely support to new health challenges. At the same time, we can avoid side effects and cure to the personal need.

Our Impact
Quantum technologies are advancing diagnostics, therapies, and healthcare operations—paving the way for more accurate, efficient, and personalized patient care.
- Laser Therapies: Optimizing laser therapies to deal with artery calcification.
- Drug and Cell Interactions: Predicting IC50 values corresponding to drug and cell line interactions.
- Improved Metabolomics: Quantum-enhanced optimization and machine learning for improved metabolomics.
- Healthcare Process Optimization: Optimizing the operational processes of healthcare providers for better patient throughput.
- Enhanced Prediction Accuracy: Enhanced prediction accuracy in non-invasive diagnostics of blood cancers.
Driving Innovation in Quantum Technology
The team at Terra Quantum, guided by global leadership in AI and quantum computing, is advancing transformative applications across industries—from materials science to mobility.

Prof. Dr. Florian Neukart
Florian has built a reputation as high-tech leader and practitioner, and advisor in innovation and future tech. He is in the Board of Trustees of the International Foundation of Artificial Intelligence and Quantum Computing, a special advisor to the Quantum Strategy Institute, on Board of Advisors of the KI Park, a co- author of Germany’s National Roadmap for Quantum Computing, on the Advisory Board of Quantum.Tech, and was a member of the World Economic Forum’s Future Council on Quantum Computing.
Before joining Terra Quantum AG in 2021, he worked at Volkswagen Group in various positions for 11 years, assuming responsibility as Director for the Group’s innovation labs in Munich and San Francisco. Preceding his career at Volkswagen, he held various management and research positions in industry, academia, and consulting. Florian studied computer science, physics, and information technology, holding Master’s degrees and diplomas in these fields as well as a Ph.D. in computer science focusing on the intersection of artificial intelligence and quantum computing.
He pursues academic research and teaching, working as assistant professor at the Leiden Institute of Advanced Computer Science teaching quantum computing. He has written books on artificial intelligence and energy, edited a book on quantum computing, and published more than 90 articles on quantum computing and various other topics ranging from materials science to self-driving vehicles.